Biberach an der Riss, Germany

Ulrike Werthmann

USPTO Granted Patents = 16 

 

 

Average Co-Inventor Count = 4.0

ph-index = 5

Forward Citations = 39(Granted Patents)


Location History:

  • Biberach, DE (2009 - 2013)
  • Biberach an der Riss, DE (2013 - 2021)
  • Ingelheim am Rhein, DE (2019 - 2024)

Company Filing History:


Years Active: 2009-2024

where 'Filed Patents' based on already Granted Patents

16 patents (USPTO):

Introduction

Ulrike Werthmann, based in Biberach an der Riss, Germany, is a prominent inventor with an impressive portfolio of 16 patents. Her work is primarily focused on pharmaceutical innovations, significantly contributing to medical treatments through her inventions.

Latest Patents

Among her latest innovations is the patent for a compound identified as (4-((3R,4R)-3-methoxytetrahydro-pyran-4-ylamino)piperidin-1-yl)(5-methyl-6-(((2R,6S)-6-(p-tolyl)tetrahydro-2H-pyran-2-yl)methylamino)pyrimidin-4-yl)methanone citrate. This invention provides a salt of a tetrahydropyranylmethylaminopyrimidine amide, specifically the citrate salt, along with pharmaceutical compositions that utilize it, processes for preparing the compound, and methods for medical treatments that leverage its properties. Another significant patent focuses on crystalline salts of N-(3-(5-((1-ethylpiperidin-4-yl)(methyl)amino)-3-(pyrimidin-5-yl)-1H-pyrrolo[3,2-b]pyridin-1-yl)-2,4-difluorophenyl)propane-1-sulfonamide, a RAF kinase inhibitor that shows potential in treating cancer and other diseases.

Career Highlights

Ulrike has worked with notable companies in the pharmaceutical sector, including Boehringer Ingelheim International GmbH and Centrexion Therapeutics Corporation. Her tenure at these organizations has allowed her to engage in groundbreaking research and development activities, driving innovations that aim to improve patient outcomes and advance medical science.

Collaborations

Throughout her career, Ulrike has collaborated with respected colleagues, including Peter Nickolaus and Rogelio Perez Frutos. These partnerships have fostered an environment of creativity and innovation, leading to the development of various critical technologies in the field of pharmaceuticals.

Conclusion

Ulrike Werthmann exemplifies the vital role of inventors in advancing medical therapies through innovative inventions. With her extensive patent portfolio and collaboration with leading companies, her contributions are shaping the future of pharmaceutical treatments. As she continues her research, the implications of her work are poised to make significant impacts in the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…